Managed Healthcare Executive November 20, 2024
Rosanna Sutherby, Pharm.D.

Binghampton University in New York state will join Mayo Clinic and at least 15 other investigators in developing an implant aimed to treat inflammatory diseases. The project, called Engage Assess SecretE (EASE): A Platform for Treating Chronic Inflammation, is meant to act as a “living pharmacy” triggering cells to produce antibodies that could target inflammatory conditions.

The EASE project, led by Alexander Revzin, Ph.D., biochemical engineer at Mayo Clinic, is funded by a $42.8 million grant from the Advanced Research Projects Agency for Health (ARPA-H), an agency nestled under the Department of Health and Human Services and the National Institutes of Health. ARPA-H funds and supports biomedical and health research with the potential for developing high-impact and transformative treatments.

Mayo...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Health System / Hospital, Provider
Podcast: Paige Nong Tracks the Use Of AI & Predictive Models In US Hospitals
HealthTech Scotland: NHS to launch new Health and Social care app as a ‘Digital Front Door’ for patients
Healthgrades names its 250 best hospitals for 2025
Mississippi cardiac center opens
'Patients want this': The case for integrative medicine in cancer care

Share This Article